Overcoming nutrient limitations for cell-based production of influenza vaccine

被引:0
|
作者
Yousef, Sara [1 ,2 ]
Kovacsovics-Bankowski, Magdalena [1 ]
Salama, Mohamed E. [3 ,4 ]
Bhardwaj, Neelam [1 ]
Steinbach, Mary [1 ]
Langemo, Amanda [1 ]
Kovacsovics, Tibor [1 ]
Marvin, James [5 ]
Binder, Mascha [6 ]
Panse, Jens [7 ]
Kroeger, Nicolaus [2 ]
Luetkens, Tim [1 ,6 ]
Atanackovic, Djordje [1 ,6 ]
机构
[1] Univ Utah, Huntsman Canc Inst, Hematol & Hematol Malignancies, Salt Lake City, UT 84112 USA
[2] Univ Med Ctr Hamburg Eppendorf, Stem Cell Transplantat, Hamburg, Germany
[3] Univ Utah, ARUP Labs, Hematopathol, Salt Lake City, UT USA
[4] Univ Utah, Dept Pathol, Salt Lake City, UT USA
[5] Univ Utah, Hlth Sci Ctr, Flow Cytometry Core Facil, Salt Lake City, UT USA
[6] Univ Med Ctr Hamburg Eppendorf, Bone Marrow Transplantat Sect Pneumol, Oncol, Hematol, Hamburg, Germany
[7] Univ Hosp RWTH Aachen, Dept Med 4, Aachen, Germany
基金
中国国家自然科学基金; 国家高技术研究发展计划(863计划);
关键词
meidum optimization; metabolic analysis; process development; influenza virus production; MULTIPLE-MYELOMA; MAINTENANCE THERAPY; DEXAMETHASONE; CS1; TRANSPLANTATION; CONSOLIDATION; BORTEZOMIB; CYTOTOXICITY; THALIDOMIDE; TARGET;
D O I
10.1080/21645515.2015.1044182
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Metabolic analysis for medium optimization represents a very useful strategy in the process development of production of vaccines in cells. During influenza vaccine production, viruses hijack host cells and take advantage of host's metabolism. As a consequence, the nutritional demand of host cells should undergo a profound change, and usually more nutrients such as glucose and amino acids should be consumed. As such, the maintaining media used in virus production processes often cannot provide sufficient nutrients, and novel methods are urged to be established to address this severe issue of nutritional limitation. A detailed study on impacts of influenza virus on cell death and metabolism, with a profound analysis of nutritional requirements during virus production process, followed by a rational medium optimization is expected to be the most straightfoward and effective strategy. This would ensure a balanced and adequate nutritional supply, which should minimize cell death and improve both cell-specific virus yield and total influenza virus production. Such a metabolic analysis-based medium optimization would lay a solid foundation for the development of cell culture technology in influenza vaccine production.
引用
收藏
页码:1606 / 1611
页数:6
相关论文
共 50 条
  • [1] A cell-based backup to speed up pandemic influenza vaccine production
    Lee, Min-Shi
    Hu, Alan Yung-Chih
    TRENDS IN MICROBIOLOGY, 2012, 20 (03) : 103 - 105
  • [2] Current cell-based Influenza vaccine production technology as pandemic contingency
    Ng, Say Kong
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (02)
  • [3] Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Children: A Narrative Review
    Mould-Quevedo, Joaquin F.
    Pelton, Stephen I.
    Nguyen, Van Hung
    VACCINES, 2023, 11 (10)
  • [4] Modelling the Economic Impact of influenza Vaccine Programs with the Cell-Based Quadrivalent Influenza Vaccine and Adjuvanted Trivalent Influenza Vaccine in Canada
    Nguyen, Van Hung
    Roy, Bertrand
    VACCINES, 2022, 10 (08)
  • [5] Cost-effectiveness of cell-based influenza vaccine in France
    Gavazzi, Gaetan
    Paccalin, Marc
    Berkovitch, Quentin
    Leleu, Henri
    Moreau, Romain
    Ciglia, Emanuele
    Burlet, Nansa
    Mould-Quevedo, Joaquin
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 1020 - 1028
  • [6] Improvement of a dendritic cell-based tumour vaccine by an influenza virus
    Sachet, M.
    Friedl, J.
    Hassler, M.
    Ploder, M.
    Stary, G.
    Stift, A.
    Bergmann, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (11) : 1000 - 1009
  • [7] New Strategies for Overcoming Limitations of Mesenchymal Stem Cell-Based Immune Modulation
    Kim, Nayoun
    Cho, Seok-Goo
    INTERNATIONAL JOURNAL OF STEM CELLS, 2015, 8 (01) : 54 - 68
  • [8] Influenza burden averted with a cell-based quadrivalent seasonal influenza vaccine compared with egg-based quadrivalent seasonal influenza vaccine
    McGovern, Ian
    Taylor, Alexandra
    Sardesai, Aditya
    Toro-Diaz, Hector
    Haag, Mendel
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 371 - 379
  • [9] Safety and Immunogenicity of Cell-Based Quadrivalent Influenza Vaccine: A Randomized Trial
    Essink, Brandon J.
    Heeringa, Marten
    Jeanfreau, Robert J.
    Finn, Daniel
    Matassa, Vince
    Edelman, Jonathan
    Hohenboken, Matthew
    Molrine, Deborah
    PEDIATRICS, 2022, 150 (05)
  • [10] Development and characterization of standard reagents for cell-based prepandemic influenza vaccine products
    Lai, Chia-Chun
    Weng, Tsai-Chuan
    Chen, Po-Ling
    Tseng, Yu-Fen
    Lin, Chun-Yang
    Chia, Min-Yuan
    Sung, Wang-Chou
    Lee, Min-Shi
    Hu, Alan Yung-Chih
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (09) : 2245 - 2251